<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>
<title>In the Pipeline</title>
<link>/home/corante/public_html/pipeline/</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:creator>derekb.lowe@gmail.com</dc:creator>
<dc:date>2013-05-09T06:46:07-05:00</dc:date>
<admin:generatorAgent rdf:resource="http://www.movabletype.org/?v=3.34" />
<sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>

<item>
<title>Your Brain Shifts Gears</title>
<link>http://pipeline.corante.com/archives/2013/05/09/your_brain_shifts_gears.php</link>
<description>Want to be weirded out? Study the central nervous system. I started off my med-chem career in CNS drug discovery, and it&apos;s still my standard for impenetrability. There&apos;s a new paper in Science, though, that just makes you roll your...</description>
<guid isPermaLink="false">76401@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Central Nervous System</dc:subject>
<dc:date>2013-05-09T06:46:07-05:00</dc:date>
</item>
<item>
<title>Tecfidera&apos;s Price</title>
<link>http://pipeline.corante.com/archives/2013/04/02/tecfideras_price.php</link>
<description>Let us take up the case of Tecfidera, the new Biogen/Idec drug for multiple sclerosis, known to us chemists as dimethyl fumarate. It joins the (not very long) list of industrial chemicals (the kind that can be purchased in railroad-car...</description>
<guid isPermaLink="false">76320@/home/corante/public_html/pipeline/</guid>
<dc:subject>Drug Prices</dc:subject>
<dc:date>2013-04-02T06:41:57-05:00</dc:date>
</item>
<item>
<title>NeuroSearch&apos;s Decline</title>
<link>http://pipeline.corante.com/archives/2013/03/21/neurosearchs_decline.php</link>
<description>If you looked at the timelines of a clinical trial, you&apos;ll notice that there&apos;s often a surprisingly long gap between when the trial actually ends and when the results of it are ready to announce. If you&apos;ve ever been involved...</description>
<guid isPermaLink="false">76290@/home/corante/public_html/pipeline/</guid>
<dc:subject>Clinical Trials</dc:subject>
<dc:date>2013-03-21T11:23:07-05:00</dc:date>
</item>
<item>
<title>A Short Rise Out of Depression</title>
<link>http://pipeline.corante.com/archives/2013/01/18/a_short_rise_out_of_depression.php</link>
<description>Here&apos;s another one to file under &quot;What we don&apos;t know about brain chemistry&quot;. That&apos;s a roomy category for sure, which (to be optimistic about it) leaves a lot of room for discovery. In that category are the observations that ketamine...</description>
<guid isPermaLink="false">76149@/home/corante/public_html/pipeline/</guid>
<dc:subject>Clinical Trials</dc:subject>
<dc:date>2013-01-18T07:53:23-05:00</dc:date>
</item>
<item>
<title>Automated Ligand Design?</title>
<link>http://pipeline.corante.com/archives/2013/01/10/automated_ligand_design.php</link>
<description>There&apos;s a paper out in Nature with the provocative title of &quot;Automated Design of Ligands to Polypharmcological Profiles&quot;. Admittedly, to someone outside my own field of medicinal chemistry, that probably sounds about as dry as the Atacama desert, but it...</description>
<guid isPermaLink="false">76128@/home/corante/public_html/pipeline/</guid>
<dc:subject>In Silico</dc:subject>
<dc:date>2013-01-10T09:37:46-05:00</dc:date>
</item>
<item>
<title>CNS Drug Development Claims Another Victim</title>
<link>http://pipeline.corante.com/archives/2012/12/20/cns_drug_development_claims_another_victim.php</link>
<description>Tiny Allon Therapeutics had an ambitious plan to go after progressive supranuclear palsy, a kind of progressive brain deterioration, and thence (they hoped) to other neurodegenerative disorders. The lead compound was davunetide, an oligopeptide derived from activity-dependent neuroprotective protein, ADNP....</description>
<guid isPermaLink="false">76088@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Central Nervous System</dc:subject>
<dc:date>2012-12-20T07:39:30-05:00</dc:date>
</item>
<item>
<title>More on That Crowdsourced CNS Research</title>
<link>http://pipeline.corante.com/archives/2012/11/23/more_on_that_crowdsourced_cns_research.php</link>
<description>I wanted to mention that the crowdfunded CNS research that I mentioned here is now in its final 48 hours for donations. Money seems to be picking up, but it&apos;ll be close to see if they can make their target....</description>
<guid isPermaLink="false">76019@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Central Nervous System</dc:subject>
<dc:date>2012-11-23T14:16:28-05:00</dc:date>
</item>
<item>
<title>The Generic Wellbutrin Problem: Whose Fault Is It?</title>
<link>http://pipeline.corante.com/archives/2012/10/18/the_generic_wellbutrin_problem_whose_fault_is_it.php</link>
<description>One of the questions I get asked most often, by people outside of the drug industry, is whether generic medications really are the same as the original branded ones. My answer has always been the same: that yes, they are....</description>
<guid isPermaLink="false">75941@/home/corante/public_html/pipeline/</guid>
<dc:subject>Regulatory Affairs</dc:subject>
<dc:date>2012-10-18T06:29:53-05:00</dc:date>
</item>
<item>
<title>Targacept Cuts Way Back</title>
<link>http://pipeline.corante.com/archives/2012/10/08/targacept_cuts_way_back.php</link>
<description>It hasn&apos;t been good over at Targacept. They had a big antidepressant failure a while back, and last month ended development of an ADHD drug, the nicotinic acetylcholine receptor ligand TC-5619. They cut back staff back in the spring, and...</description>
<guid isPermaLink="false">75917@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Central Nervous System</dc:subject>
<dc:date>2012-10-08T10:21:52-05:00</dc:date>
</item>
<item>
<title>Crowdfunding A CNS Project</title>
<link>http://pipeline.corante.com/archives/2012/10/05/crowdfunding_a_cns_project.php</link>
<description>Ethan Perlstein at Princeton is the main author of this research on sertraline that I blogged about earlier this year. Now he&apos;s looking to crowdfund his next research project, on the neuronal effects of amphetamines. He&apos;s trying to raise $25,000...</description>
<guid isPermaLink="false">75912@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Central Nervous System</dc:subject>
<dc:date>2012-10-05T06:32:58-05:00</dc:date>
</item>
<item>
<title>Various Links Of Stuff</title>
<link>http://pipeline.corante.com/archives/2012/09/20/various_links_of_stuff.php</link>
<description>Swamped with all sorts of stuff today - when science marches on, you have to make sure that it&apos;s not leaving its bootprints on your back. But I do have some interesting links: The bluest of blue-sky brain research, funded...</description>
<guid isPermaLink="false">75874@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Central Nervous System</dc:subject>
<dc:date>2012-09-20T10:02:01-05:00</dc:date>
</item>
<item>
<title>Eli Lilly&apos;s Drumbeat of Bad News</title>
<link>http://pipeline.corante.com/archives/2012/08/31/eli_lillys_drumbeat_of_bad_news.php</link>
<description>Eli Lilly has been getting shelled with bad news recently. There was the not-that-encouraging-at-all failure of its Alzheimer&apos;s antibody solanezumab to meet any of its clinical endpoints. But that&apos;s the good news, since that (at least according to the company)...</description>
<guid isPermaLink="false">75843@/home/corante/public_html/pipeline/</guid>
<dc:subject>Cardiovascular Disease</dc:subject>
<dc:date>2012-08-31T06:42:15-05:00</dc:date>
</item>
<item>
<title>Is Ampyra Any Good?</title>
<link>http://pipeline.corante.com/archives/2012/08/14/is_ampyra_any_good.php</link>
<description>I wrote here about Ampyra, the multiple sclerosis drug from Acorda Therapeutics, one that came close to the record for &quot;simplest chemical matter in a marketed drug&quot;. (As it happens, Biogen Idec is making sure that it doesn&apos;t even have...</description>
<guid isPermaLink="false">75807@/home/corante/public_html/pipeline/</guid>
<dc:subject>Clinical Trials</dc:subject>
<dc:date>2012-08-14T06:47:16-05:00</dc:date>
</item>
<item>
<title>Getting Drug Research Really, Really Wrong</title>
<link>http://pipeline.corante.com/archives/2012/08/09/getting_drug_research_really_really_wrong.php</link>
<description>The British Medical Journal says that the &quot;widely touted innovation crisis in pharmaceuticals is a myth&quot;. The British Medical Journal is wrong. There, that&apos;s about as direct as I can make it. But allow me to go into more detail,...</description>
<guid isPermaLink="false">75801@/home/corante/public_html/pipeline/</guid>
<dc:subject>Business and Markets</dc:subject>
<dc:date>2012-08-09T10:45:39-05:00</dc:date>
</item>
<item>
<title>Closure at the Neurosciences Institute?</title>
<link>http://pipeline.corante.com/archives/2012/08/08/closure_at_the_neurosciences_institute.php</link>
<description>There doesn&apos;t seem to be any mention of it on their web site, but the Neurosciences Institute in San Diego/La Jolla may be closing up shop. A reader received an e-mail about a lab equipment auction at that address, and...</description>
<guid isPermaLink="false">75799@/home/corante/public_html/pipeline/</guid>
<dc:subject>The Central Nervous System</dc:subject>
<dc:date>2012-08-08T07:43:56-05:00</dc:date>
</item>


</channel>
</rss>